The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking
here.
According to Fortune Business Insights, the global cancer biomarkers market was valued at USD 38.14 billion in 2024 and is projected to grow from USD 42.87 billion in 2025 to USD 74.62 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.2% during the forecast period. In 2024, North America dominated the market with a 35.99% share.
Published by
sachi toshniwal,
2025-07-30 00:20:55
Cancer Biomarkers Market Forecast: Technological Disruptions in Biomarker Testing Platforms 2032
According to Fortune Business Insights, the global cancer biomarkers market was valued at USD 38.14 billion in 2024 and is projected to grow from USD 42.87 billion in 2025 to USD 74.62 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.2% during the forecast period. In 2024, North America dominated the market with a 35.99% share.
Keywords: Cancer Biomarkers Market
Click to View FlipBook Version